Is modified retroperitoneal lymph node dissection (MRLND) still feasible in the treatment of patients with clinical stage I non-seminomatous testicular cancer?-Reference-Cited by-同舟云学术

Is modified retroperitoneal lymph node dissection (MRLND) still feasible in the treatment of patients with clinical stage I non-seminomatous testicular cancer?

Published:1994-12 Issue:4 Volume:26 Page:471-477
ISSN:0301-1623
Container-title:International Urology and Nephrology
language:en
Short-container-title:International Urology and Nephrology

Author:

Sosnowski M.,Jeromin L.,Płużanska A.

Publisher

Springer Science and Business Media LLC

Subject

Urology,Nephrology

Link

http://link.springer.com/content/pdf/10.1007/BF02768020.pdf

Reference18 articles.

1. Aass, N., Fossa, S. D., Lien, H. H., Stenwig, E., Paus, E., Kaalhus, O.: Is routine primary retroperitoneal lymph node dissection still justified in patients with low node stage non-seminomatous testicular cancer?Br. J. Urol. 65, 385 (1990).

2. Foster, R. S., Donohue, J. P., Bihrle, R.: Stage A nonseminomatous testis carcinoma: rationale and results of nerve-sparing retroperitoneal lymphadenectomy.Urol. Int., 46, 294 (1991).

3. Frang, D., Farkas, L., Götz, F., Székely, J. Jr.: Prognosis of testicular tumour since the introduction of complex therapy.Int. Urol. Nephrol. 21, 1 (1989).

4. Hoeltl, W., Pont, J., Kosak, D., Honetz, N., Marberger, M.: Treatment decision of stage I non-seminomatous germ cell tumours based on the risk factor “vascular invasion”.Br. J. Urol., 69, 83 (1992).

5. EORTC Genitourinary Group Monograph 5: Progress and Controversies in Oncological Urology;A. Horwich,1988

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of Occult Metastasis in Clinical Stage I Nonseminoma: A Systematic Review;Journal of Clinical Oncology;2003-11-15